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ABSTRACT  The organization of intermediate-sized  filaments (IF) of the cytokeratin type was studied 
in  cultures  of  PtK2 cells  in  which  typical  IF  structures  are  maintained  during  mitosis,  using  a 
monoclonal antibody (KG 8.13). This antibody reacts, in immunoblotting experiments, with the larger 
of the two major cytokeratin  polypeptides present in these cells but, using standard immunofluores- 
cence microscopy procedures, does not react with the cytokeratin filaments abundant in interphase 
cells, in striking contrast to various antisera and other monoclonal cytokeratin antibodies. In the same 
cell  cultures,  however,  the  antibody  does  react  with  cytokeratin  filaments  of  mitotic  and  early 
postmitotic  cells.  The specific  reaction with cytokeratin  filaments of mitotic cells  only is due to the 
exposure  of the  specific  immunologic  determinant  in  mitosis  and  its  masking  in  interphase  cells. 
Treatment of interphase cells with both Triton X-100 as well as with methanol and acetone alters the 
cytokeratin  filaments and allows them to react with this monoclonal  antibody. A similar unmasking 
was noted  after treatment  with  buffer  containing  2  M  urea or low concentrations  of trypsin.  We 
conclude  that  the  organization  of cytokeratin,  albeit  still  arranged  in  typical  IF,  is  altered  during 
mitosis  of PtK2 cells. 
Intermediate-sized filaments (IF)  j of vertebrates are cytoplas- 
mic structures that are notoriously stable, both mechanically 
and chemically, and resist extractions in buffers of a broad 
range  of ionic  strengths  and  pH  values  (for reviews,  see 
references 1-4). Different types of IF have been distinguished 
by subunit polypeptide composition and by immunological 
criteria and their specific expression has been related to routes 
of cell differentiation (1-3,  5-7).  Yet they all  share some 
common principles of morphology and homologies of amino 
acid sequence (1-4, 8-10). In spite of their remarkable stabil- 
ity, IF may undergo  redistribution of filaments as well  as 
rearrangements of subunit proteins in living cells. It has been 
described that arrays of vimentin filaments are reorganized 
during mitosis (11-15) and drug-induced perinuclear aggre- 
gation (11,  16-17) and similar observations have been made 
for cytokeratin IF in mitosis of some epithelial cells (6,  12, 
18,  19). In most cases such re-distributions have been inter- 
J Abbreviations used in this paper:  IF, intermediate-sized  filaments; 
PIK2, cultured rat kangaroo cells. 
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preted as altered distributions of intact IF that do not involve 
intrafilamentous changes such as disassembly and re-assembly 
of IF subunits, in agreement with electron microscopic obser- 
vations of normaMooking IF in all stages of mitosis of  various 
cultured cells of mesenchymal (11, 13, 15) and epithelial (19) 
origin. By contrast, certain epithelial cells exhibit a drastic, 
transient change of IF organization during mitosis in which 
IF are unravelled into different, yet still insoluble and poly- 
meric structures that aggregate into variously sized, spheroidal 
masses  containing cytokeratin (20-22).  These observations 
suggest that the structural state of at least certain IF is phys- 
iologically regulated. In the present study, we describe obser- 
vations indicating that systematic, though less conspicuous 
changes of cytokeratin IF organization also occur in mitotic 
cells which, at the electron microscopic level, maintain typical 
IF morphology such as cultured rat kangaroo (PtK2)  cells. 
These observations have been made possible  by the use of a 
monoclonal antibody, I~ 8.13 (23), which recognizes a cy- 
tokeratin determinant, the exposure of which is modulated 
during the cell cycle. 
1255 MATERIALS  AND  METHODS 
Cells:  PtK2  cells were grown as previously described (19). For enrichment 
of mitotic stages some cell cultures were treated with 10  -6 M colcemid for 12- 
24 h (19). 
Antibodies:  The  monoclonal  murine  antibody  KG  8.13 (lgG2) has 
recently been described in detail (23). Conventionally prepared antibodies (IgG 
fractions or affinity-purified) obtained from guinea pigs and rabbits immunized 
with epidermal prekeratins from bovine muzzle have previously been described, 
including their reaction with IF of PtK2 cells (3, 6, 18, 20, 24, 25). Guinea pig 
antibodies  to  vimentin  have  also  been  described  (6,  24). To  control  the 
stainability of  cytokeratin 1F in all phases of  the cell cycle of  PtK2 cells, we also 
used other monoclonal antibodies to cytokeratins (20). 
Immunofluorescence  Microscopy:  PtK2 cells grown on  glass 
coverslips to various densities (from  1 d after plating to confluency) were rinsed 
with  phosphate-buffered  saline at room temperature.  The standard  fxation 
procedure included dipping for 5 rain in -20"C methanol  and then for 1 min 
in -20" acetone, followed by air-drying. Variations of this procedure included 
the following: 
(a) Extended (2 or 5 rain) or repeated (6 x  1 rain) incubations  in acetone. 
(b)  Use  of ethanol  instead  of methanol.  (c)  Rinsing  in  PBS, followed by 
incubation  for 5 min in 10 mM Tris-HCl buffer (pH 7.2) containing  140 mM 
NaCI and 0, 1, or 5 mM MgCI2  (cf. reference 26) before application of  methanol 
and acetone. (d) The same as c, except methanol and acetone were at 0*C or 
at room temperature.  (e) Rinsed cells incubated in Tris-buffer containing  140 
mM NaCI and  1% Triton X-100 (with or without  1 mM MgCI2) for various 
periods of time (1, 2, 3, 4, 5, and  10 min), followed by an additional  wash (5 
min) in Tris-buffer, prior to application of first antibody (cf. reference 26). (f) 
The same as in e, except with fixation in -20"C methanol and -20"C acetone 
before application of first antibody. (g) The same as e, except with additional 
wash (5 min) in PBS. (h) As done in f, except methanol  and acetone were at 
4"C. (i) The same as in f, except incubation  in methanol  and acetone  were 
both at room temperature.  (j) After treatment with buffer containing  Triton 
X-100 (as above) cells were incubated  in high salt buffer (10 mM Tris-HCl, 
140 mM NaCI,  1.5 M KCI, pH 7.2) for 5 min or 30 min, then rinsed in PBS 
containing  1 mM MgCI2, prior to direct application of first antibody. (k) The 
same as in j,  except after  rinsing  in PBS the specimens  were incubated  in 
methanol and acetone of  various temperatures (-20"C, 4"C, room temperature). 
(1) The same as in f, except  1% Nonidet  P-40 was used instead of Triton X- 
100. (m) After standard treatment with methanol and acetone cells were dipped 
into PBS containing 2 M urea (ultrapure) for a few seconds, followed by washes 
in PBS. (n) Cells treated  with  methanol  and acetone  were dipped  into PBS 
containing trypsin (~20 #g/ml), followed by washes in PBS. 
Incubation  with  the  respective  first  antibody  was  for 45  min  at  room 
temperature,  followed by several washes in PBS, and incubation  with second 
antibody.  In the case of the murine antibodies  second antibodies  were either 
fluorescein- or rhodamine-labeled  rabbit anti-mouse  IgG (freshly prepared or 
purchased from Miles-Yeda, Rehovot,  Israel) or rhodamine-labeled  goat anti- 
bodies to mouse (Cappel Laboratories,  Cochranville,  PA). When  guinea  pig 
antibodies were used in the first place they were visualized with rhodamine-  or 
fiuorescein-conjugated  goat  or rabbit  antibodies  to guinea  pig  IgG (freshly 
prepared or purchased  from Miles-Yeda or Cappel Laboratories). After incu- 
bation with the specific second antibodies specimens were rinsed twice in PBS, 
air-dried and  mounted in Mowiol (Hoechst,  Frankfurt,  Federal  Republic  of 
Germany). 
Photomicrographs  were  taken  with  a  Zeiss  photomicroscope  III (Zeiss, 
Oberkochen, Federal Republic of Germany). For double label immunofluores- 
cence, both the murine and the guinea pig antibodies were applied at the same 
time (of. reference 27). Controls for specificity of the second antibodies used in 
double immunofluorescence  were routinely included. 
Electron Microscopy:  Cells  grown on cover  slips were  fixed and 
processed for electron microscopy of ultrathin sections as previously described 
(19). For immunoelectron  microscopy cells were treated  in the specific way 
used for immunofluorescence  microscopy, then were incubated  with the first 
antibody  for I h at room temperature.  After washing three times with  PBS, 
goat antibodies  to mouse IgG that had been coupled to 5 nm colloidal gold 
particles (Janssen Chemicals, Beerse, Belgium) were added in PBS and incu- 
bated for 2 h. After three washes with PBS, specimens were fixed with 2.5% 
glutaraldehyde for 15 min, followed by OsO4-fixation, and processed for ultra- 
thin sectioning as described (28). 
Gel Electrophoresis and Detection of Antigens:  Polypeptides 
of whole PtK2 cells and cytoskeletons made therefrom (29) were separated by 
gel electrophoresis, transferred on nitrocellulose paper sheets and examined by 
the immunoblotting technique as previously described (23). 
R  ES U LTS 
The monoclonal antibody K~ 8.13 recognizes, in epithelia of 
man and cow, a determinant present in almost all members 
of the "basic  subfamily" of cytokeratin polypeptides as well 
as in cytokeratin D (No. 18 of the human catalog; cf. reference 
30) of man and cow (23). In cytoskeletons of PtK: cells, two 
major cytokeratin polypeptides have been identified,  in ad- 
dition to vimentin (3, 29, 31). One has an apparent Mr value 
of 54,000 and is related  to cytokeratin "A" of other species, 
the  other  is  more  acidic,  has  an  electrophoretic  mobility 
similar to that ofactin and appears to be related to component 
"D"  of  higher  mammalian  species  (3,  23,  29).  Of  these, 
antibody  K~  8.13  reacts  only  with  the  larger  cytokeratin 
(Fig.  1). 
Immunofluorescence microscopy of PtK2 cells in interphase 
with  conventional cytokeratin  antibodies  of rabbits  guinea 
pigs reveals an intricate meshwork of wavy cytokeratin fibrils 
characteristic  of this cell type (not shown; cf. references  3, 6, 
7,  12,  18,  20,  31,  32).  The  same  fibrillar  meshwork  is also 
seen with various monoclonal murine antibodies (not shown; 
cf. references  20, 32, 33). In mitotic PtK2 cells this meshwork 
is  altered  but  fibriUar structures  are  still  well  discerned,  in 
agreement  with  previous  reports  (12,  19,  20).  By  contrast, 
antibody KG  8.13  does  not stain  interphase  PtK2  cells  but 
reacts only with mitotic stages (Fig.  2). This specific reaction 
in mitotic PtK2 cells only is illustrated  by double immunoflu- 
orescence microscopy in Fig.  3, a-d which also demonstrate 
that this reaction is not restricted to prophase-telophase stages 
of mitosis (Fig.  3, a and b), but extends to postmitotic stages 
of early G1 phase of both daughter cells (Fig. 3, c and d). This 
specific reaction of antibody K~ 8.13 with cytokeratin struc- 
tures  of  perimitotic  but  not  interphase  PtK2  ceils  is  not 
restricted to mitoses that have rounded off but is also seen in 
mitotic cells that have remained fiat, thus demonstrating that 
it is related to the mitosis as such but not the morphological 
shape change. It is further evident that this change in antigenic 
reaction with PtK2 mitoses  is also seen  in thin cytoplasmic 
projections as they occur in some normal mitoses and, more 
frequently, in mitotic stages  arrested  by treatment with col- 
cemid (data not shown). 
FIGURE  1  Cytoskeletal  polypeptides 
obtained from PtK2 cells after extraction 
with Triton  X-100  and  high  salt  buffer 
have been separated by SDS PAGE and 
stained with Coomassie Blue (lane  l) or 
blotted on  nitrocellulose paper and al- 
lowed  to  react  with  monoclonal anti- 
body KG 8.13 followed by reaction with 
12Sl-labeled protein A  (lane 2, autoradi- 
ofluorography). The two horizontal bars 
denote the  two cytokeratins  1  (upper) 
and 2 (lower). V, vimentin; A, actin. Note 
that only cytokeratin 1 reacts with the 
antibody. 
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uniform when both methanol and acetone were used at 4"C 
or at room temperature rather than at -20"C. Unmasking of 
the  determinant  recognized by antibody K6  8.13  has  also 
been achieved by brief treatments with 2 M urea and trypsin. 
Electron microscopic examination has confirmed that an- 
tibody K6  8.13  specifically binds to bundles of cytokeratin 
filaments. Positive decoration on IF bundles is seen in mitotic 
cells  as  well  as  in  interphase  cells  treated  with  both  the 
detergent and the organic solvents (data not shown). 
DISCUSSION 
FIGURE 2  Immunofluorescence microscopy of mitoses-rich  PtK2 
cell cultures  after staining  with  murine monoclonal antibody Kc 
8.13. Note that antibody Kc 8.13 reacts exclusively  with mitotic and 
early postmitotic cells.  Nuclei of unstained  cells are indicated by 
N. Bar, 40 ~m. x  820. 
These observations of a  specific reaction of antibody K6 
8.13 with cytokeratin filaments of mitotic but not interphase 
PtK2 cells suggest that this reaction is the result of  the masking 
of the determinant recognized in denatured cytokeratin (Fig. 
1) during interphase. The strong staining of cytokeratin fibrils 
in interphase PtK2 cells with various other conventional and 
monoclonal antibodies demonstrates the accessibility of the 
cytokeratin filaments to murine immunoglobulins. Therefore, 
we examined various preparative conditions which, in inter- 
phase cells, might unmask the determinant recognized by K6 
8.13.  It has been found that when cells are extracted first with 
buffer containing  Triton  X-100  or Nonidet  P-40  and  then 
with methanol and acetone as described under methods f-I 
above significant fibrillar staining with antibody I~  8.13  is 
seen in interphase PtK2 cells (Fig. 4, a-c). Positive reaction is 
seen in  all  cells although  the  distinctiveness of the  fibrillar 
fluorescence is often variable from cell to cell in  the  same 
culture.  Double  label  immunofluorescence  microscopy  of 
PtK2 cells treated in this way with guinea pig antibodies and 
with  murine monoclonal antibody K6  8.13  shows that the 
fibrillar structures stained with antibody KG 8.13 are identical 
to those stained by cytokeratin antibodies that are positive 
also with cells processed according to the standard procedure. 
Inclusion of millimolar concentrations of Mg  2+ or Ca  2+ in the 
various buffers has not resulted in significant differences of 
this  umasking  effect.  This  unmasking  of the  determinant 
Our results present the case of a specific cell cycle-dependent 
re-arrangement  of IF  structures  that  is  recognized  by  the 
selective masking and unmasking of a specific immunologic 
determinant in cytokeratin filaments. Selective masking has 
been discussed by Lazarides et al. (34) as a likely explanation 
of an unexpected reaction of another type of IF, desmin, with 
a monoclonal antibody (D76) that reacts with desmin only in 
later stages of myotube differentiation but not in early myo- 
tubes. However, direct proof by experimental unmasking of 
this determinant has not been presented for this case.  Our 
observations in PtK2 cells demonstrate cell cycle-dependent 
masking of an IF determinant by experimental unmasking. 
This occurrence of a  selective and  complete masking of a 
determinant in an IF system should be taken as a reason for 
concern and caution in interpreting negative results obtained 
in immunolocalization studies, especially when monoclonal 
antibodies are  used.  The phenomenon  described  here may 
also explain unexpected heterogeneities of reactivity in inter- 
phase cells of the same culture (for examples, see references 
2 l, 33, 35, 36). It may also be relevant for some observations 
in  frozen tissue sections, and failures to certain monoclonal 
or conventionally obtained antibodies to react with fibrils of 
some epithelial cells but not with those of others (e.g., refer- 
ences 6, 7, 25, 32, 33, 37, 38) may reflect differential masking 
rather than differences of expression. Woodcock-Mitchell et 
al. (39) have presented an example of a monoclonal antibody 
that does not bind to its cytokeratin determinant in suprabasal 
layers of epidermis and have suggested that this might be due 
to selective masking in situ. We propose to include, as controls 
for possible masking of the type described here, immunoblot- 
ting tests on proteins from the specific cell colonies or layers 
under question as well as treatments with unmasking reagents 
as they have been successful in this study. 
Antibody KG 8.13  reacts with a determinant of a group of 
cytokeratin polypeptides present in diverse mammalian spe- 
cies (23). Interestingly, this determinant is differently exposed 
during  interphase  in  cultured  cells  from  various  species. 
Whether this different reactivity of the same determinant in 
different cells reflects functional differences or only tolerance 
of changes in an unimportant region of this molecule is not 
known. 
The accessibility of the cytokeratin determinant recognized 
in  PtK2  cells  during  mitosis  but  not  during  most  of the 
interphase indicates that the organization of cytokeratin fila- 
ments is not constant but goes through systematic and dy- 
namic changes, both when the cell enters mitosis and when it 
re-establishes its interphase architecture.  PtK cells maintain 
intermediate-sized  filament  structures  during  mitosis,  al- 
though changes in their display have been noticed by electron 
RAPIO COMMUNiCATiONS  1257 FIGURE 3  Double label immunofluorescence microscopy of PtK2  cells, using guinea pig antibodies against cytokeratin (a and c; 
same as in Fig. 2, a-c) and murine antibody KG 8.13 (b and d). Note that antibody KG 8.13 reacts only with filaments of mitotic 
cells (a and b) and postmitotic cells of early 61 phase. (c and d). Bars, 30/~m. x  900. 
1258  R^PtD  COMMUN~C^T~ONS FIGURE  4  Immunofluorescence microscopy of PtK2 cells treated sequentially with Triton X-100 as well as methanol and acetone 
using monoclonal antibody KG 8.13 (a-c). Note that cytokeratin filaments positively stained with antibody KG 8.13 are recognized 
in cells extracted in this way (a, survey; b, a large and a small cell; c, an interphase cell, in the left, and two mitotic cells in the 
upper right). Bars, 30 tzm. (a) X 700; (b) x  750; (c) x  750. 
microscopy (19) as well as immunofluorescence microscopy 
(14,  18), different from many other epithelial cells in which 
cytokeratin filaments are transformed into spheroidal aggre- 
gates of non-IF structures (20-22). Now our observations that 
cytokeratin filaments of mitotic PtK2  cells are not identical 
to those of interphase PtK2  cells  and  can be clearly distin- 
guished by monoclonal antibody I~  8.13  suggest that  per- 
imitotic changes of IF organization may be much more com- 
mon, albeit not necessarily as dramatic as in those cells which 
transiently transform their cytokeratin filaments into nonfi- 
brillar aggregates (20-22). 
Our experiments do  not  allow us to decide whether  the 
masking of the K~ 8.13 determinant in cytokeratin filaments 
of PtK2  interphase cells is due (i) to the specific association 
with a  noncytokeratin protein or (ii)  to an intrinsic change 
in  the  arrangement of the  cytokeratin polypeptides.  Treat- 
ment with Triton X-100 or Nonidet P-40 does not detectably 
change the electron microscopic appearance of  these filaments 
(cytokeratins are even capable of reconstituting intermediate- 
sized filaments in vitro in the presence of 1% Triton X-100, 
data not shown). The various treatments used for unmasking 
could "loosen" the specific polypeptide arrangement within 
IF or extract a  masking component. It is also possible that 
the perimitotic changes in the K~ 8.13 determinant of PtK2 
cells are related to modifications of cytokeratins (for reports 
of increased phosphorylated of vimentin in mitosis, see ref- 
erences 40, 41). The observed changes in IF organization may 
have,  beyond the  structural  aspect,  functional  importance: 
the surface pattern of IF which,  in the living cell,  provide a 
large area for potential structure-bound reactions may not be 
constant and inactive but may be involved in the regulation 
of other cellular activities. 
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